Skip to content
healthcare.dev
Get a free key

XELJANZ

NDC 0069-1029, tofacitinib, solution, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0069-1029
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213082
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1029 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOFACITINIB CITRATE1 mg/mL

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0069-1029-02000691029021 BOTTLE in 1 CARTON (0069-1029-02) / 240 mL in 1 BOTTLE (0069-1029-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cf74ba2f-afc5-4baa-8594-979c889a5831

Use it

Look up 0069-1029 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1029 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0069-1029. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.